CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · New debt or obligation
- 4 Open-market sale Director sold 2,000 shares at $86.96 ($173,920)
- 4 Open-market sale Director sold 11,600 shares at $87.30 ($1,012,680)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award Director acquired 11,882 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 144/A Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144/A Insider Sale of Securities
- 4 Planned sale Director sold 2,970 shares at $76.88 ($228,334)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 1 of 69 · 1,361 filings